The treatment of GBM cell lines with the soluble epoxide hydrolase inhibitor t-AUCB induced the activation of p38 MAPK, MAPKAPK2, and HSP27 in GBM cell lines, resulting in cells protection from apoptosis [74]. The gene discussed is MAPKAPK2; the disease is glioblastoma.